Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
Matinas BioPharma Holdings reports 2018 executive compensation
By ExecPay News
Published: October 1, 2020
Matinas BioPharma Holdings reported fiscal year 2018 executive compensation information on October 1, 2020.
In 2018, five executives at Matinas BioPharma Holdings received on average a compensation package of $500K, a 54% decrease compared to previous year.
Average pay of disclosed executives at Matinas BioPharma Holdings
Jerome D. Jabbour, Chief Executive Officer, received $1.3M in total, which decreased by 1% compared to 2017. 64% of Jabbour's compensation, or $804K, was in option awards. Jabbour also received $84K in bonus and $366K in salary.
Roelof Rongen, Chief Executive Officer, received a compensation package of $400K, which decreased by 79% compared to previous year. 54% of the compensation package, or $217K, was in other compensation.
Theresa Matkovits, Chief Development Officer, earned $306K in 2018.
Raphael Mannino, Chief Scientific Officer, received $295K in 2018, which decreases by 50% compared to 2017.
Gary Gaglione, Chief Financial Officer, earned $243K in 2018, a 55% decrease compared to previous year.
Related executives
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
You may also like
Source: SEC filing on October 1, 2020.